SDA Ventures Provides Strategic Guidance to NOX Technologies

SDA Ventures Provides Strategic Guidance to NOX Technologies in its
Acquisition by Nu Skin Enterprises 
COLUMBIA, MARYLAND -- (Marketwire) -- 12/18/12 -- SDA Ventures LLC
(SDA), a strategic consulting firm focused on the health & wellness
and nutrition sectors, announced the successful completion of a
significant engagement in the life sciences field. SDA provided
strategic consulting services to NOX Technologies, Inc. (NOX) leading
to its acquisition by Nu Skin Enterprises, Inc. (NYSE:NUS).  
NOX is a biotechnology and biodiagnostic company based in Malvern,
Pennsylvania. The acquisition of NOX by a subsidiary of Nu Skin
includes the acquisition of technology and patents, including
previously licensed technology used in connection with Nu Skin's
anti-aging research efforts and ultimately incorporated into the
development of certain ageLOC(R) skin care products. The acquisition
also includes other intellectual property assets that Nu Skin may use
in future research. 
According to Thomas B. Shelton, chief executive officer of NOX
Technologies, "This merger is the culmination of many years of
working with Nu Skin researchers. NOX Technologies' translation of
the basic science around arNOX paved the way for this unique
technology to be incorporated into Nu Skin's anti-aging research and
development efforts." 
Shelton added, "NOX engaged SDA to assist us in assessing long-term
strategic opportunities for NOX Technologies and our unique
intellectual property. The professionals at SDA were instrumental in
NOX's decision to pursue a merger between NOX Technologies and Nu
Skin and were key contributors in negotiating the transaction. The
broad business perspective and industry expertise that SDA brought to
the table revealed that the best outcome for NOX's technology and its
shareholders was the transaction with Nu Skin." 
Steve Dubin, Principal of SDA, stated, "It was great to work with the
NOX management team over the past year and to participate in the
events leading up to this acquisition." Added David Abramson,
Principal of SDA, "I am pleased that SDA could provide value to the
NOX team during its strategic decision-making process and assist them
in realizing the value of their science and hard work." 
About NOX Technologies, Inc. and arNOX 
Established in 2003, NOX Tech
nologies, Inc. is a biotechnology and
biodiagnostic company focused on the identification, characterization
and detection of cell surface proteins relating to aging. Through its
research and development efforts, NOX Technologies identified agents
that interact with age-related ECTO-NOX proteins (arNOX). arNOX
proteins are a class of external NADH oxidase or ECTO-NOX proteins
that are believed to reside on the external portion of cell
membranes. arNOX is a unique enzymatic protein that is believed to
generate superoxide at the cell surface, and superoxide has been
proposed as a major cause of skin aging. 
About SDA Ventures LLC 
SDA Ventures LLC is based in Columbia, Maryland and was founded by
former top executives of Martek Biosciences Corporation, which was
acquired by Royal DSM N.V. in February 2011. SDA focuses on assisting
emerging growth and middle-market companies, primarily in the health
& wellness and nutritional products markets, on matters including
corporate development, business acquisition, customer relations,
growth strategies and corporate finance. 
Contacts:
Vida Strategic Partners
Stephanie Diaz
415-675-7401
sdiaz@vidasp.com
 
 
Press spacebar to pause and continue. Press esc to stop.